SOX2 has been reported to promote invasion, migration, and metastasis in melanoma, colorectal cancer, glioma, gastric cancer, ovarian cancer and hepatocellular carcinoma [20, 35–38]. This evidence concerns the gene SOX2 and central nervous system cancer.